One of our senior scientists in discovery, Juliana Barclay, will be presenting at Society for Immunotherapy of Cancer (SITC) 2022 in Boston this Friday, November 11. Juliana will present on the discovery and development of t-cell receptors for adoptive T-cell therapy...
ImmunoScape’s CEO Choon-Peng Ng is featured in Endpoints. Endpoints highlights ImmunoScape’s $14M funding round, our use of machine learning to discover TCR-T cell therapies focused on solid tumors, and our progress toward the clinic. You can read the full...
ImmunoScape To Present at the 7th Annual CAR-TCR Summit San Diego, California and Singapore – September 14, 2022 – ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics, today announced...
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors Anzu Partners led the $14M financing round with participation from Amgen Ventures and EDBI ImmunoScape’s Deep Immunomics and machine learning platforms...
Come see us at 7th Annual CAR-TCR Summit 9/19 – 9/23 in Boston, MA Dan MacLeod VP of Discovery Dan be presenting on “Discovery of TCRs targeting novel antigens using Deep Immunomics”.
